In a significant step towards COVID-19 response, the USFDA has approved the first diagnostic test to detect both COVID-19 and influenza A and B. Patients can collect the sample at home and ship it to the associated laboratory for analysis under a healthcare professional order. The FDA has authorized the use of the COVID-19 +Flu RT-PCR Test for prescription use. This approval is going to help address the fight against COVID-19 in the middle of the flu season. This test has enabled the public to get home-collected samples to get quick answers. This will also allow patients to be safe and comfortable at their homes while their results await.
In your opinion, how reliable would this test be? Option A. Yes, it will be extremely reliable Option B. No, it won’t be that reliable Option C. More research needed Source: United States Food and Drug Administration
